📊 MDAIW Key Takeaways
Is MDAIW a Good Investment? Thesis Analysis
Spectral AI exhibits severe fundamental deterioration with negative stockholders' equity of -$5.7M, indicating liabilities exceed all assets. The company is burning cash at an unsustainable rate with -$9.9M operating cash flow while revenue declined 33.6% YoY, and despite improved net loss per share, absolute profitability metrics remain deeply negative across all measures.
Why Buy MDAIW? Key Strengths
- Solid gross margin of 45.4% indicates viable unit economics at production level
- Substantial cash position of $15.4M provides runway for operations
- Net loss improved 50.1% YoY suggesting some operational adjustments or cost controls
MDAIW Investment Risks to Consider
- Negative stockholders' equity of -$5.7M represents technical insolvency and solvency crisis
- Operating cash burn of -$9.9M annually with only $15.4M cash implies runway of less than 18 months at current burn rate
- Revenue collapse of 33.6% YoY combined with -43.8% operating margin indicates business model failure at scale
- Current ratio of 0.94x below 1.0 signals immediate liquidity concerns and inability to cover short-term obligations
- Interest coverage ratio of -8.6x shows inability to service debt from operations
Key Metrics to Watch
- Quarterly revenue trend and customer retention rates
- Monthly cash burn rate and path to cash flow breakeven
- Gross margin sustainability as company scales or restructures
- Total liabilities trajectory and refinancing needs
- Operating leverage improvements and cost structure reduction
MDAIW Financial Metrics
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
MDAIW Profitability Ratios
MDAIW vs Healthcare Sector
How Spectral AI, Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is MDAIW Overvalued or Undervalued?
Based on fundamental analysis, Spectral AI, Inc. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
MDAIW Balance Sheet & Liquidity
MDAIW 5-Year Financial Trend & Growth Analysis
5-Year Trend Summary: Spectral AI, Inc.'s revenue has grown significantly by 17% over the 5-year period, indicating strong business expansion. The most recent EPS of $-0.85 indicates the company is currently unprofitable.
MDAIW Growth Metrics (YoY)
MDAIW Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2025 | $6.3M | $2.9M | $0.11 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
MDAIW Capital Allocation
MDAIW SEC 10-K & 10-Q Filing Analysis
Access official SEC EDGAR filings for Spectral AI, Inc. (CIK: 0001833498)
📋 Recent SEC Filings
❓ Frequently Asked Questions about MDAIW
What is the AI rating for MDAIW?
Spectral AI, Inc. (MDAIW) has an AI rating of STRONG SELL with 92% confidence, based on fundamental analysis of SEC EDGAR filings.
What are MDAIW's key strengths?
Claude: Solid gross margin of 45.4% indicates viable unit economics at production level. Substantial cash position of $15.4M provides runway for operations.
What are the risks of investing in MDAIW?
Claude: Negative stockholders' equity of -$5.7M represents technical insolvency and solvency crisis. Operating cash burn of -$9.9M annually with only $15.4M cash implies runway of less than 18 months at current burn rate.
What is MDAIW's revenue and growth?
Spectral AI, Inc. reported revenue of $19.7M.
Does MDAIW pay dividends?
Spectral AI, Inc. pays dividends, with $0.8M distributed to shareholders in the trailing twelve months.
Where can I find MDAIW SEC filings?
Official SEC filings for Spectral AI, Inc. (CIK: 0001833498) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is MDAIW's EPS?
Spectral AI, Inc. has a diluted EPS of $-0.29.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is MDAIW a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Spectral AI, Inc. has a STRONG SELL rating with 92% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is MDAIW stock overvalued or undervalued?
Valuation metrics for MDAIW: ROE of N/A (sector avg: 15%), net margin of -38.5% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy MDAIW stock in 2026?
Our dual AI analysis gives Spectral AI, Inc. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is MDAIW's free cash flow?
Spectral AI, Inc.'s operating cash flow is $-9.9M, with capital expenditures of N/A. FCF margin is -50.5%.
How does MDAIW compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin -38.5% (avg: 12%), ROE N/A (avg: 15%), current ratio 0.94 (avg: 2).